(NASDAQ: CBUS) Cibus's forecast annual revenue growth rate of 71.4% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 85.29%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.87%.
Cibus's revenue in 2025 is $4,846,000.On average, 3 Wall Street analysts forecast CBUS's revenue for 2025 to be $254,703,442, with the lowest CBUS revenue forecast at $232,140,275, and the highest CBUS revenue forecast at $287,463,425. On average, 3 Wall Street analysts forecast CBUS's revenue for 2026 to be $373,702,452, with the lowest CBUS revenue forecast at $340,617,039, and the highest CBUS revenue forecast at $417,093,158.
In 2027, CBUS is forecast to generate $1,572,641,886 in revenue, with the lowest revenue forecast at $520,688,467 and the highest revenue forecast at $2,624,595,305.